Targeted Protein Degradation Market: By Modality (PROTACs/Bifunctional Degraders, Molecular Glues, Other [LYTACs, AUTACs]); Target Protein (Transcription Factors, Kinases, Nuclear Receptors, Scaffolding Proteins); Indication (Oncology, Immunology & Inflammation, Neurodegeneration, Others); Development Stage (Preclinical, Clinical, Approved); End User (Biopharma, Academic & Research, CROs)— Market Size, Industry Dynamics, Opportunity Analysis and Forecast For 2026–2035
The targeted protein degradation market is estimated at USD 690.8 million in 2025 and is projected to reach USD 5,004.9 million by 2035, growing at a CAGR of 21.9% over the forecast period 2026–2035. Read More
- Last Updated: 15-Jul-2026 | Format:
![pdf]()
![powerpoint]()
![excel]()
| Report ID: AA07261884
| Report ID: AA07261884Fill out the form below to receive a free sample of this report
Features | Type of License | ||||
 Data Book | Single User |   Multi User |  Corporate | ||
| e-Access | ✓ | ✓ | ✓ | ✓ | |
User Sharing | 1 User Only | 1 User Only | Up to 7 Users | Unlimited User Access | |
⨉ | ⨉ | ⨉ | ✓ | ||
Free Customization | No Free Customization | Up To 30 hrs work | Up To 60 hrs work | Up To 80 hrs work | |
Deliverable |
| ⨉ | ✓ | ✓ | ✓ |
| ✓ | ⨉ | ✓ | ✓ | |
| ⨉ | ⨉ | ⨉ | ✓ | |
Analyst Support | 2-Months Analyst Support | 4-Months Analyst Support | 7-Months Analyst Support | One Year Analyst Support | |
Free Report update in next update cycle | ⨉ | ⨉ | ⨉ | ✓ | |
Free Industry Update (Within 180 days) | ⨉ | ⨉ | ⨉ | ✓ | |
Benefit | Up to 10% off on Post Purchase | Up to 20% off on Post Purchase | Up to 30% off on Post Purchase | Up to 40% off on Post Purchase | |
